PubMed · 2012 · 16 citations · 21 references
MedicineOncologyPathologyMetastasisMolecular OncologyMolecular PathologyBiomarkers In PathologyCancer BiomarkersColorectal CancerImmuno-oncology BiomarkersTumor AntigensTumor MarkersCancer Metastasis BiomarkersColorectal Cancer BiomarkersColorectal Cancer PrognosisLymph Node MetastasesLymph Node Metastasis BiomarkersMarker Gene ExpressionPrognostic Marker AssessmentProtein Expression Levels
BACKGROUND: Lymph node (LN) evaluation is an important factor for the prognosis of colorectal cancer (CRC). The purpose of our study was to investigate the effectiveness of E74-like factor 3 (ELF3) and carcinoembryonic antigen (CEA) as useful markers to detect LN metastases in CRC. MATERIALS AND METHODS: We examined the mRNA expression of ELF3 and CEA in LNs and tissues from 22 patients with CRC and in controls with ulcerative colitis (UC) by real-time quantitative reverse transcription polymerase chain reaction, as well as by hematoxylin-eosin staining. RESULTS: ELF3 and CEA expression showed statistically significant differences among four LN groups: LNs from patients with CRC categorized into three Dukes' stages and LNs from patients with UC (p<0.001 and p<0.001, respectively). We found a statistical correlation between the expression levels of both markers in patients with CRC compared with each Dukes' stage. CONCLUSION: ELF3, as a gene marker, may be sufficiently practical to detect LN metastases of CRC, rather than CEA.
21
Pericolonic tumor deposits in patients with T3N+M0 colon adenocarcinomas
Neal S. Goldstein, Jerrold R. Turner · Cancer · 2000 · 210 citations · Full text
Treatment of Rectal Cancer by Low Anterior Resection with Coloanal Anastomosis
Philip B. Paty, Warren E. Enker, Alfred M. Cohen et al. · Annals of Surgery · 1994 · 186 citations
ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis
Chuan-Hsiung Chang, Gary K. Scott, Wen-Lin Kuo et al. · Oncogene · 1997 · 182 citations